Determining the safety and efficacy of prophylactic defibrotide administration in children, adolescents, and young adults with high-risk sickle cell disease (SCD) or beta thalassemia major following myeloimmunoablative conditioning (MAC) and haploidentical stem cell transplantation utilizing CD34+ selection and T-cell (CD3) addback (IND127812) Meeting Abstract
| Authors: | Schaefer, E.; Milner, J.; Hung, J.; Ayello, J.; Shi, Q.; Talano, J. A.; Moore, T. B.; Friedman, D.; Dozor, A. J.; Klejmont, L.; Mahanti, , H.; Morris, E.; Fabricatore, S.; Mintzer, E.; Flower, A.; Cooke, K. R.; Cairo, M. S. |
| Abstract Title: | Determining the safety and efficacy of prophylactic defibrotide administration in children, adolescents, and young adults with high-risk sickle cell disease (SCD) or beta thalassemia major following myeloimmunoablative conditioning (MAC) and haploidentical stem cell transplantation utilizing CD34+ selection and T-cell (CD3) addback (IND127812) |
| Meeting Title: | 2022 Tandem Meetings of ASTCT and CIBMTR |
| Journal Title: | Transplantation and Cellular Therapy |
| Volume: | 28 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Apr 23-26 |
| Meeting Location: | Salt Lake City, UT |
| ISSN: | 2666-6375 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-03-01 |
| Start Page: | S341 |
| Language: | English |
| DOI: | 10.1016/S2666-6367(22)00598-X |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: 438 -- Located within the section named "Poster Session - Hemoglobinopathies, Primary Immune Deficiencies and Inborn Errors Of Metabolism - Clinical" |
